Last reviewed · How we verify
Cord Tissue Mesenchymal Stromal Cells
Cord Tissue Mesenchymal Stromal Cells is a Biologic drug developed by Joanne Kurtzberg, MD. It is currently in Phase 2 development for Treatment of cerebral palsy.
Cord Tissue Mesenchymal Stromal Cells are thought to exert therapeutic effects through immunomodulation and tissue repair.
Cord Tissue Mesenchymal Stromal Cells are thought to exert therapeutic effects through immunomodulation and tissue repair. Used for Treatment of cerebral palsy.
At a glance
| Generic name | Cord Tissue Mesenchymal Stromal Cells |
|---|---|
| Sponsor | Joanne Kurtzberg, MD |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
They may promote tissue repair by releasing growth factors and cytokines, and modulate the immune system by suppressing inflammation and promoting regulatory T-cell function.
Approved indications
- Treatment of cerebral palsy
Common side effects
- Graft-versus-host disease
- Infection
Key clinical trials
- Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells (PHASE1)
- Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients (PHASE2)
- Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint (PHASE1, PHASE2)
- Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction (PHASE2)
- The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain (PHASE1)
- Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease (EARLY_PHASE1)
- A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy (PHASE2)
- Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cord Tissue Mesenchymal Stromal Cells CI brief — competitive landscape report
- Cord Tissue Mesenchymal Stromal Cells updates RSS · CI watch RSS
- Joanne Kurtzberg, MD portfolio CI
Frequently asked questions about Cord Tissue Mesenchymal Stromal Cells
What is Cord Tissue Mesenchymal Stromal Cells?
How does Cord Tissue Mesenchymal Stromal Cells work?
What is Cord Tissue Mesenchymal Stromal Cells used for?
Who makes Cord Tissue Mesenchymal Stromal Cells?
What development phase is Cord Tissue Mesenchymal Stromal Cells in?
What are the side effects of Cord Tissue Mesenchymal Stromal Cells?
Related
- Manufacturer: Joanne Kurtzberg, MD — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Treatment of cerebral palsy
- Compare: Cord Tissue Mesenchymal Stromal Cells vs similar drugs
- Pricing: Cord Tissue Mesenchymal Stromal Cells cost, discount & access